Crossmark

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome

Crossref DOI link: https://doi.org/10.1038/s41408-025-01248-2

Published Online: 2025-03-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soureas, Konstantinos

Malandrakis, Panagiotis

Papadimitriou, Maria-Alexandra

Minopoulos, Christos

Ntanasis-Stathopoulos, Ioannis

Liacos, Christine-Ivy

Gavriatopoulou, Maria

Kastritis, Efstathios

Dimopoulos, Meletios-Athanasios https://orcid.org/0000-0001-8990-3254
Scorilas, Andreas

Avgeris, Margaritis

Terpos, Evangelos https://orcid.org/0000-0001-5133-1422
Funding

Funding for this research was provided by:

European Commission (Project 101097094)
License Information

Text and Data Mining valid from 2025-03-15

Version of Record valid from 2025-03-15
More Information

Article History

Received: 31 October 2024

Revised: 24 February 2025

Accepted: 6 March 2025

First Online: 15 March 2025

Competing interests

: The authors declare no competing interest.

Document is current

Any future updates will be listed below